UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000026330 |
|---|---|
| Receipt number | R000030245 |
| Scientific Title | Efficacy and safety of the biosimilar Infliximab in the patients with Crohn's disease |
| Date of disclosure of the study information | 2017/02/28 |
| Last modified on | 2022/09/03 10:57:48 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/02/28 12:56:35 | ||
| 2 | Update | 2017/05/23 17:17:01 | Recruitment status |
|
| 3 | Update | 2017/09/01 15:18:23 | Recruitment status Last follow-up date Date of closure to data entry Date analysis concluded |
|
| 4 | Update | 2018/08/31 17:12:06 | Last follow-up date Date of closure to data entry Date trial data considered complete |
|
| 5 | Update | 2019/09/02 14:09:43 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 6 | Update | 2020/03/02 21:44:14 | Number of participants that the trial has enrolled Results Delayed Results Delay Reason Results Delay Reason |
|
| 7 | Update | 2020/09/01 17:28:15 | Date of IRB |
|
| 8 | Update | 2022/09/03 10:57:48 | Recruitment status |
